SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by Atria Investments Inc

Atria Investments Inc grew its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 9,016 shares of the exchange traded fund’s stock after purchasing an additional 188 shares during the quarter. Atria Investments Inc’s holdings in SPDR S&P Biotech ETF were worth $891,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in XBI. Kingsview Wealth Management LLC grew its stake in shares of SPDR S&P Biotech ETF by 3.8% in the first quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock worth $332,000 after acquiring an additional 127 shares in the last quarter. Edgestream Partners L.P. purchased a new stake in SPDR S&P Biotech ETF during the 1st quarter worth about $336,000. Bessemer Group Inc. increased its holdings in SPDR S&P Biotech ETF by 1.7% during the 1st quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock worth $87,572,000 after purchasing an additional 15,794 shares during the period. Lake Street Advisors Group LLC acquired a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at about $814,000. Finally, National Bank of Canada FI boosted its stake in shares of SPDR S&P Biotech ETF by 2,414.5% in the 1st quarter. National Bank of Canada FI now owns 210,636 shares of the exchange traded fund’s stock valued at $18,565,000 after buying an additional 202,259 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of SPDR S&P Biotech ETF stock opened at $91.83 on Monday. The business has a 50-day simple moving average of $98.95 and a 200-day simple moving average of $96.17. The company has a market cap of $7.00 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $69.32 and a one year high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.